Abstract
This study was undertaken to investigate the pharmacology of human serotonin (5-HT)1D receptor sites by measuring two functional cellular responses, inhibition of forskolin-stimulated cAMP formation and promotion of cell growth, using transfected rat C6-glial cell lines and a broad series of 5-HT receptor agonists. Stable and separate transfection of a pcDNA3 or pRcRSV plasmid, each containing a cloned human 5-HT1D receptor gene, in rat C6-glial cells was confirmed with RT PCR of 5-HT1D receptor mRNA and radioligand binding with [3H] 5-carboxamidotryptamine (5-CT) and [3H] sumatriptan. The 5-HT1D receptor density was 350 and 1050 fmol/mg protein for the C6-glial/pcDNA3/5-HT1D and C6-glial/pRcRSV/5-HT1D cell line, and forskolin (100 μM)-induced cAMP formation was inhibited by 45 and 78% in the presence of 1 μM 5-HT, respectively. A comparison of the intrinsic agonist activities for sixteen 5-HT receptor ligands with their corresponding binding affinities for the human 5-HT1D receptor site showed similar results for both cell lines with the exception of the partial agonist m-trifluoro-phenyl-piperazine (TFMPP). Three classes of compounds were observed: 1. efficacious agonists, such as 5-CT, 5-methoxytryptamine, 5-HT, sumatriptan, bufotenine, 5-methoxy-3(1,2,3,6-tetrahydro-4-pyridinyl)1H-indole (RU 24,969), tryptamine and 8-hydroxy-2(di-n-propilamino)tetralin (8-OH-DPAT), with agonist potency close to their binding affinity; 2. the partial agonists metergoline, 7-trifluoromethyl-4(4-methyl-l-piperazinyl)-pyrolo-(1,2-a) quinoxaline (CGS 12066B), 1-naphthylpiperazine and 2′-methyl-4-(5-methyl-[1,2,4]oxadiazol-3-yl)-biphenyl-4-carboxylic acid [4-methoxy-3-(4-methylpiperazin-1-yl)-phenyl]-amide (GR 127,935) with marked intrinsic agonist activity but at concentrations higher than their binding affinity; and 3. the silent antagonists ritanserin, ketanserin and methiothepin, apparently free of intrinsic agonist activity, with antagonist potency close to their binding affinity. The cAMP data were further supported by the observed promotion of cell growth by stimulation of both transfected cell lines with sumatriptan under serum-free conditions; half-maximal stimulation was obtained at 4.4 nM (C6-glial/pcDNA3/5-HT1D) fully in agreement with its EC50-value (5.7 nM) for inhibition of cAMP formation. This growth promoting effect was antagonised by 1 μM methiothepin and not observed in pcDNA3-plasmid-transfected and non-transfected C6-glial cells. A comparative study with a C6-glial/pcDNA3/5-HT1B cell line expressing a similar amount of cloned human 5-HT1B receptors (B max: 360 fmol/mg protein) showed almost no intrinsic agonist activity for metergoline, 1-naphtylpiperazine and GR 127,935. Together with the 5-HT1D receptor binding selectivity and antagonist activity of ketanserin and ritanserin, the findings define important pharmacological differences between cloned human 5-HT1D and 5-HT1B receptor sites.
Similar content being viewed by others
References
Abdul M, Anezinis PE, Logothetis CJ, Hoostein NM (1994) Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonist. Anticancer Res 14: 1215–1220
Adham N, Romanienko P, Hartig P, Weinshank RL, Branchek T (1992) The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine 1Dβ receptor. Mol Pharmacol 41: 1–7
Adham N, Borden LA, Schechter LE, Gustafson EL, Cochran TL, Vaysse PJJ, Weinshank RL, Branchek TA (1993) Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways. Naunyn-Schmiedeberg's Arch Pharmacol 348:566–575
Bateman DN (1993) Sumatriptan. Lancet 341: 221–224
Boddeke HWGM, Fargin A, Raymond JR, Schoeffter P, Hoyer D (1992) Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studies in transfected HeLa cells. Naunyn-Schmiedeberg's Arch Pharmacol 345: 257–263
Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Branchek T, Hou-Yu A, Durkin M, Urquhart D, Weinshank R (1992) Both 5-HT1Dα and 5-HT1Dβ receptor subtypes appear to be autoreceptors: evidence from in situ hybridisation studies. Abstracts from 2nd International Symposium on Serotonin, Kluwer Academic Publishers, Dordrecht, p 9
Cattaneo MG, Palazzi E, Bondiolotti G, Vicentini LM (1994) 5-HT1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma. Eur J Pharmacol 268: 425–430
Chazel G, Ralston HJ III (1987) Serotonin-containing structures in the nucleus raphe dorsalis of the cat: an ultrastructural analysis of dentrites, presynaptic dendrites, and axon terminals. J Comp Neurol 259: 317–329
Cortés R, Mengod G, O'Dowd B, Artigas F, Palacios JM (1992) 5HT1B and 5-HT1D receptors in mammalian brain: visualisation of their mRNAs and binding sites by in situ hybridisation and ligand binding autoradiography (abstract). Soc Neurosci 18: 198.10
Davidson C, Stamford JA (1994) Not only 5-HT1A but also 5-HT1B receptors modulate serotonin efflux in the rat dorsal raphe nucleus. In: Monitoring molecules in neuroscience. Louilot A, Durkin T, Spampinato U, Cador M (eds) Seignosse: University of Bordeaux, p 195–196
Davidson C, Stamford JA (1995) Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5HT1B and 5-HT1D autoreceptors. Br J Pharmacol 114: 1107–1109
Hamblin MW, Metcalf MA (1991) Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Mol Pharmacol 40: 143–148
Hamblin MW, McGuffin RW, Metcalf MA, Dorsa DM, Merchant KM (1992) Distinct 5-HT1B and 5-HT1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors. Mot Cell Neurosci 3: 578–587
Hamel E, Bouchard D (1991) Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites. Br J Pharmacol 102: 227–233
Hamel E, Fan E, Linville D, Ting V, Villemure J-G, Chia L-S (1993) Expression of mRNA for the serotonin 5-hydroxytryptamine1Dβ receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 44: 242–246
Hamon M, Emerit MB, El Mestikawy S, Gallisot MC, Gozlan H (1991) Regional differences in the transduction mechanisms of 5-HT receptors in the mammalian brain. In: Cardiovascular pharmacology of 5-HT: prospective therapeutic applications Saxena PR, Wallis DI, Woulters W Bevan P (eds) Kluwer Academic Publishers, Dordrecht, pp 41–59
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46: 157–203
Jin H, Oksenberg O, Ashkenazi A, Peroutka SJ, Duncan AMV, Rozmahel R, Yang Y, Mengod G, Palacios JM, O'Dowd BF (1992) Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem 267: 5735–5738
Kalen P, Karlson M, Wiklund L (1985) Possible excitatory amino acid afferents to nucleus raphe dorsalis of the rat investigated with retrograde wheat germ agglutinin and D-(3H)asparate tracing. Brain Res 360: 285–297
Kaumann AJ, Frenken M, Posival H, Brown AM (1994) Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. Circulation 90: 1141–1153
Kenakin T (1993) Pharmacological analysis of drug-receptor interaction (2nd edn). Raven Press, New-York
Leonhardt S, Herrick-Davis K, Titeler M (1989) Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein. J Neurochem 53: 465–471
Libert F, Passage E, Parmentier M, Simons M, Vassart G, Mattei M (1991) Chromosomal mapping of Al and A2 adenosine receptors VIP receptor, and a new subtype of serotoniD receptor. Genomics 11: 225–227
Metcalf MA, McGuffin RW, Hamblin MW (1992) Conversion of the human 5-HT1Dβ serotonin receptor to the rat 5-HT1B ligand-binding phenotype by THR355 site directed mutagenesis. Biochem Pharmacol 44: 1917–1920
Moskowitz MA (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 13: 307–311
Moskowitz MA, Nozaki K, Kraig RP (1993) Neocortical spreading depression provokes the expression of C-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 13: 1167–1177
Munson PJ, Rodbard D (1980) Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 107: 220–239
Oksenberg D, Masters SA, O'Dowd BF, Jin H, Havlik S, Peroutka SJ, Ashkenazi A (1992) A single amino acid difference confers major pharmacological variation between human and rodent 5HT1B receptors. Nature 360: 161–163
Ottervanger JP, Paalman HJA, Boxma GL, Stricker BHC (1993) Transmural myocardial infarction with sumatriptan. Lancet 341: 861–862
Parker EM, Grisel DA, Iben LG, Shapiro RA (1993) A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors. J Neurochem 60: 380–383
Pauwels PJ, Palmier C (1994) Differential functional activity of 5-hydroxytryptamine receptor ligands and beta adrenergic receptor antagonists at 5-hydroxytryptamine1B receptor sites in chinese hamster lung fibroblasts and opossum renal epithelial cells. J Pharmacol Exp Ther 270: 938–945
Pauwels PJ, Colpaert FC (1995) The 5-HT1D receptor antagonist GR 127,935 is an agonist at cloned human 5-HT1Dα receptor sites. Neuropharmacology 34: 235–237
Pauwels PJ, Reihsaus E, Palmier C, Journot L, Lyons J, Colpaert FC (1995a) Ketanserin differentiates between cloned human 5-HT1Dα receptors and cloned human 5-HT1D\, sheep and bovine caudate nucleus 5-HTID receptor sites. Cell Pharmacol 2:183–191
Pauwels PJ, Palmier C, Colpaert FC (1995b) Cloned human 5-HT1Dα receptors mediating inhibition of cAMP in permanently transfected CHO-KI cells: pharmacological characterisation of agonists, partial agonists and antagonists. Cell Pharmacol 2: 49–57
Pauwels PJ, Colpaert FC. Differentiation between partial and silent 5-HT1D\ receptor antagonists using rat and Chinese hamster ovary cell lines permanently transfected with a cloned human 5-HT1Dβ receptor gene. Biochem Pharmacol (in press)
Pauwels PJ, Wurch gnT, Amoureux gnM-C, Palmier C, Colpaert FC. Stimulation of cloned human 5-HT1Dβ receptor sites in stably transfected C6-glial cells promotes cell growth. J Neurochem (in press)
Peroutka SJ (1994) Pharmacological differentiation of human 5-HT1B and 5-HT1D receptors. Biol Signals 3: 217–222
Rebeck GW Maynard KI, Hyman BT, Moskowitz MA (1994) Selective 5-HT1Dα serotonin receptor gene expression in trigeminal ganglia: implication for antimigraine drug development. Proc Natl Acad Sci 91: 3666–3669
Schoeffter P, Hoyer D (1989) 5-hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity: pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some β-adrenoreceptors antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 340: 285–292
Seumen K, Pouysségur J (1990) Serotonin as a growth factor. Biochem Pharmacol 39: 985–990
Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphe neurones to 5-HT1A and 5-HT1B agonists. Synapse 1: 3–9
Starkey SJ, Skingle M (1994) 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus. Neuropharmacology 33: 393–402
Varrault A, Bockaert J, Waeber C (1992) Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis. Mol Biol Cell 3: 961–969
Weinshank RL, Zgombick JM, Macchi MJ, Branchek TA, Hartig PR (1992) Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ. Proc Natl Acad Sci 89: 3630–3634
Willett F, Curzen N, Adams J, Armitage M (1992) Coronary vasospasm induced by subcutaneous sumatriptan. Br Med J 304: 1415
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pauwels, P.J., Palmier, C., Wurch, T. et al. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors. Naunyn-Schmiedeberg's Arch Pharmacol 353, 144–156 (1996). https://doi.org/10.1007/BF00168751
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168751